Arteriosclerosis
Not yet recruitingStudy of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
- Disease:Arteriosclerosis
- Substances:–
Slovakia- Participants:18–64 years · 65+ years
- Sponsor:Amgen Inc.
Rare diseases
Investigational molecules
Locations
Back to Slovakia79 clinical trials in Nitra, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on inflammatory bowel diseases, including studies of novel therapies for both Crohn's Disease and Ulcerative Colitis. Research evaluates treatments like obefazimod and risankizumab for managing moderate to severe cases.
Comprehensive research into cardiovascular diseases, examining new treatments for heart attacks, stroke prevention, and atherosclerosis. Studies include evaluation of medications like asundexian and inclisiran for various cardiac conditions.
Advanced trials in multiple sclerosis treatment, testing innovative therapies like frexalimab and remibrutinib. Research focuses on reducing relapse rates and improving long-term patient outcomes.
Studies examining treatments for chronic kidney disease and related conditions, including research on combination therapies with dapagliflozin and investigations into hypertriglyceridemia management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.